Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma.
In the present study we have evaluated the prognostic significance of ploidy levels and proliferative activity in 279 cases of large bowel carcinomas which were included in a surgical prospective randomized trial. Ploidy levels and proliferative activity were determined on nuclei isolated from paraffin-embedded tissues of 279 colorectal carcinoma patients, with a mean follow-up of 51.9 months. Product limit survival analysis demonstrated a borderline significant association (P = 0.0689 by generalized Breslow; P = 0.0336 by generalized Savage) between ploidy and survival, with a 75th quantile survival of 49.8 months for patients with diploid tumors and 35.9 months for patients with aneuploid tumors. After stratification for staging, Dukes' C cases showed a statistically significant association between tumor ploidy and survival (P = 0.0224 by generalized Breslow, P = 0.0110 by generalized Savage). Product limit survival analysis for proliferative activity and survival showed a similar outcome with the strongest association in Dukes's C stage of disease (75th quantile survival of 38.9 months for low proliferative and 18.0 months for high proliferative tumors).
D000782:Aneuploidy; D002455:Cell Division; D003110:Colonic Neoplasms / Q000235:genetics* / Q000601:surgery; D004247:DNA / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D009367:Neoplasm Staging; D011123:Polyploidy; D011379:Prognosis; D011446:Prospective Studies; D011897:Random Allocation; D012004:Rectal Neoplasms / Q000235:genetics* / Q000601:surgery; D012189:Retrospective Studies
D004247:DNA